首页|表皮生长因子受体在非小细胞肺癌中的表达及与患者临床特征的关系

表皮生长因子受体在非小细胞肺癌中的表达及与患者临床特征的关系

Expression of epidermal growth factor receptor in non-small cell lung cancer and its relationship with clinical characteristic

扫码查看
目的 探讨表皮生长因子受体(EGFR)在非小细胞肺癌(NSCLC)中的表达及与患者临床特征的关系.方法 收集95例NSCLC患者的NSCLC组织和癌旁正常组织,采用免疫组化法检测各组织中EGFR表达情况,比较不同临床特征NSCLC患者NSCLC组织中的EGFR表达情况.结果 NSCLC组织中EGFR阳性表达率明显高于癌旁正常组织,差异有统计学意义(P<0.01).有淋巴结转移和预后差NSCLC患者NSCLC组织中EG-FR阳性表达率分别高于无淋巴结转移和预后良好患者,差异均有统计学意义(P<0.05).结论 EGFR在NSCLC患者中高表达,EGFR检测可用于诊断NSCLC,并预测预后,与患者淋巴结转移密切相关.
Objective To investigate the expression of epidermal growth factor receptor(EGFR)in non-small cell lung cancer(NSCLC)and its relationship with clinical characteristics.Method NSCLC tissues and adjacent normal tis-sues of 95 NSCLC patients were collected,EGFR expression in different tissues were detected by immunohistochemical method,and the expression of EGFR in NSCLC tissues of NSCLC patients with different clinical characteristics were compared.Result The positive expression rate of EGFR in NSCLC tissues was significantly higher than that in adjacent normal tissues,the difference was statistically significant(P<0.01).The positive expression rates of EGFR in NSCLC tis-sues of NSCLC patients with lymph node metastasis and poor prognosis were higher than those of patients without lymph node metastasis and with good prognosis,the differences were statistically significant(P<0.05).Conclusion EGFR is highly expressed in patients with NSCLC.EGFR detection can be used to diagnose NSCLC and predict prognosis,which is closely related to lymph node metastasis.

epidermal growth factor receptornon-small cell lung cancerimmunohistochemical methodprognosislymph node metastasis

李俏然、赵信喜、张新阁、刘向阳

展开 >

驻马店市中心医院病理科,河南 驻马店 463000

表皮生长因子受体 非小细胞肺癌 免疫组化法 预后 淋巴结转移

2024

癌症进展
中国医学科学院,北京协和医学院

癌症进展

影响因子:1.004
ISSN:1672-1535
年,卷(期):2024.22(12)